Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids by unknown
Assembly and Routing of von WiUebrand Factor Variants: 
The Requirements for Disulfide-linked Dimerization 
Reside within the Carboxy-Terminal 151 Amino Acids 
Jan Voorberg, Ruud Fontijn, Jero Calafat,* Hans Janssen,* Jan A. van Mourik, and Hans Pannekoek 
Departments of Molecular Biology and Blood Coagulation, Central Laboratory of the Netherlands Red Cross Blood Transfusion 
Service, Amsterdam, The Netherlands; *  Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands 
Abstract.  The precursor protein of von Willebrand 
factor (pro-vWF) consists of four different repeated do- 
mains,  denoted D1-D2-D'-D3-A1-A2-A3-D4-B1-B2-B3- 
C1-C2, followed by a  carboxy-terminal region of 151 
amino acids without obvious internal homology. Previ- 
ously, we have shown the requirement of the domains 
D1, D2, D', and D3 of pro-vWF in the assembly of 
pro-vWF dimers into multimers.  Here, we define the 
domains of vWF involved in dimerization,  using dele- 
tion mutants of full-length vWF cDNA transiently ex- 
pressed in monkey kidney COS-1  cells. It is shown 
that only the carboxy-terminal  151 amino acid residues 
of vWF are required for dimerization.  In addition,  by 
analyzing a construct,  encoding only the carboxy- 
terminal  151 amino acids of vWF, we find that the for- 
mation Of dimers is an event independent of other do- 
mains present on pro-vWF, such as the domains C1 
and C2 previously suggested to be involved in dimer- 
ization.  Furthermore,  it is shown that a deletion mu- 
tant of vWF, lacking the carboxy-terminal  151  amino 
~tcid residues and thus unable todimerize,  is proteo- 
lytically degraded in the ER.  In contrast, a mutant 
protein,  composed only of the carboxy-terminal  151 
amino acids of vWF, and able to dimerize,  is trans- 
ported from the ER in a  similar fashion as wild-type 
vWF.  The role of the ER in the assembly of vWF is 
discussed with regard to the data presented in this pa- 
per on the intracellular  fate of several vWF mutant 
proteins. 
T 
HE routing of  secretory and membrane proteins through 
the cell depends both on information  contained in the 
poly-peptide chain and on the ability of the cell to re- 
spond to this information  (Munro and Pelham,  1987; Gould 
et al.,  1987; Medda et al.,  1989). Besides the information 
contained by the primary amino acid sequence of a protein, 
other parameters are of importance for correct routing  of 
secretory and membrane proteins (for review  see Lodish, 
1988; Rose and Doms, 1988; Hurtley and Helenius, 1989). 
Using the influenza virus hemagglutinin,  it has been shown 
that correct folding upon translation  in the ER is a prerequi- 
site for transport  through  the cell  (Gething  et al.,  1986; 
Copeland et al., 1988). In addition,  for oligomeric proteins, 
as for example  immunoglobulins  and the T cell receptor, 
correct assembly appears to be an absolute prerequisite for 
normal  routing  (Bole et al., 1986;  Gething  et al.,  1986; 
Copeland et al.,  1988;  Lippincott-Schwartz  et al.,  1988). 
The assembly of oligomers occurs in the ER where appar- 
ently a discrimination  is made between correctly assembled 
and unassembled proteins.  Recently, a group of ER-resident 
proteins,  termed polypeptide chain binding (PCB) 1  proteins, 
1. Abbreviations  used in this paper: IPB, immunopreeipitation buffer; PCB, 
polypeptide chain binding; vWF, yon WiUebrand factor. 
have been implicated  in this discriminatory process (for re- 
view see Rothman,  1989). 
von Willebrand  factor (vWF), a large, adhesive glycopro- 
tein involved in the adhesion of platelets to a damaged vessel 
wall, is yet another protein assembled in the ER into dimers 
(Wagner and Marder,  1984). The vWF protein is synthesized 
in megakaryocytes and endothelial cells, and its biosynthesis 
has been studied extensively (for review see Verweij, 1988a). 
A unique property of the vWF protein is that, in addition to 
dimer formation,  it is able to assemble into a heterogeneous 
series of multimeric  structures with molecular weights rang- 
ing from 400,000 to 20,000,000  (Van Mourik and Bolhuis, 
1978; Hoyer and Shainoff, 1980; Ruggeri and Zimmerman, 
1981). Assembly of dimers into multimeric vWF has been 
localized to the Golgi apparatus (Wagner and Marder,  1984). 
In this compartment, part of the multimers is packaged into 
specialized  organdies, the so-called Weibel-Palade bodies 
and another part of the vWF protein, consisting of relatively 
small multimers,  is secreted constitutively  (Loesberg et al., 
1983; Sporn et al., 1985). Proteolytic processing of the pro- 
vWF protein, as evidenced by release of the pro-polypeptide 
of the pro-vWF precursor,  occurs at the arginine (763)-serine 
(764) peptide bond (Verweij et al., 1988). Reeently, we have 
shown  that furin,  an endopeptidase with a  specificity  for 
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pro-vWF at the indicated peptide bond (Van der Ven et al., 
1990).  As yet, the intracellular location of furin in the en- 
dothelial cell is unknown, vWF secreted by the constitutive 
pathway is encountered as partially processed molecules. In 
contrast, vWF secreted upon stimulation with endothelial 
cell agonists is released by the Weibel-Palade bodies in a 
fully processed form. 
The determination of the primary amino acid sequence of 
vWF, both by molecular cloning of the full-length cDNA and 
by direct amino acid sequencing, has revealed a pronounced 
structure of homologous domains, denoted A, B, C, and D, 
respectively (Sadler et al., 1985; Verweij et al., 1986; Shel- 
ton-Inloes et al., 1986; Bonthron et al., 1986; Titani et al., 
1986).  The propolypeptide of the vWF, constituting the do- 
mains D1 and D2, is preceded by a signal peptide of 22 ami- 
no acids. The remainder of the vWF molecule encodes ma- 
ture vWF, consisting of the domains D', D3, A1, A2, A3, D4, 
B1, B2, B3, C1, C2 and, finally, a carboxy-terminal stretch 
of amino acids exhibiting no internal homology. Recently, 
we and others have defined the domains involved in multimer 
assembly of vWF by expressing full-length vWF cDNA and 
mutants derived thereof in heterologous cells (monkey kid= 
ney COS-I) (Verweij et al.,  1987, 1988; Wise et ai.,  1988; 
Voorberg et al., 1990). Besides the involvement of the amino- 
terminal D domains in multimer assembly, we were able to 
show that multimer assembly can proceed independently of 
dimerization. Electron microscopy has implicated the car- 
boxy-terminal part of vWF in dimerization, an observation 
further substantiated by Marti and co-workers who showed 
that, in vWF multimers derived from plasma, intermolecular 
disulfide bridges are located in the extreme carboxy-termi- 
nus beyond domain C2  (Fretto et al.,  1986;  Marti et al., 
1987).  However, in those studies the involvement in dimer- 
ization of other domains at the carboxy-terminus of vWF has 
not been excluded. In this respect, it should be noted that the 
domains C1 and C2 may participate in this process as well, 
since the localization of cysteine residues corresponds with 
those of homologous domains on the oligomeric proteins, 
thrombospondin and procollagen (Hunt and Baker,  1987). 
To obtain conclusive evidence on the domains of vWF in- 
volved in the assembly of  dimers, we constructed a set of  mu- 
tant vWF cDNAs and expressed these derivatives in COS-1 
cells. The properties of  the resulting mutant proteins with re- 
gard to dimerization are described. Furthermore, we have 
analyzed the routing of both wild-type and the mutant vWF 
proteins. Finally, the relationship between dimer- and mul- 
timer assembly and the routing of  the different (mutant) vWF 
proteins through the cell will be discussed. 
Materials and Methods 
Materials 
Restriction enzymes and DNA modifying enzymes were obtained from 
Bethesda Research Laboratories (Gaithersburg, MD).-The Sequenase kit 
was from the U.S. Biochemical Corp. (Cleveland, OH). Immunoreagents 
were either from the Central Laboratory of the Netherlands Red Cross 
Blood Transfusion Service (Amsterdam, The Netherlands) or from Dako- 
patts (Glostrup,  Denmark).  Radioactive chemicals were purchased from 
Amersham Radiochemical (Amershum, UK).  Synthetic oligonuclcotides 
were prepared with an automated DNA synthesizer (model 381A; Applied 
Biosystems, Foster City,  CA).  Culture  media and antibiotics were pur- 
chased from Gibco Laboratories (Paisley, UK) and from Flow Laboratories 
(Irvine, UK). Gelatin-Sepharose, Protein A-Sepharose, cyanogen bromide- 
activated Sepharose-4B, and plasmid pSVL were obtained from Pharmacia 
LKB (Uppsala, Sweden). Endoglycosidase H was obtained from Boehringer 
(Mannheim, FRG). 
Plasmid Constructions 
The plasmids pSVLvWF and pSVLE have been described previously (Voor- 
berg et al., 1990).  A partial Eco [] digestion of pSVLE was performed to 
insert an Eco [] fragment containing the previously described mutant vWF 
cDNA that lacks the propolypeptide (Verweij et al.,  1987).  The resulting 
plasmid was designated pSVLvWFdelpro. To construct a  mutant eDNA 
lacking the domains C1 and C2 of vWE an 1,841-bp Bgl II-Eco [] frag- 
ment (position: 7065-8804) was subcloned into double-stranded M13mp9 
phage DNA, digested both with Barn HI and Eco [] (Messing and Vieira, 
1982). The deletion of the domains C1 and C2 was made by using the M13- 
gapped duplex mutagenesis procedure (Kramer et al.,  1984).  As an out- 
loop-primer in this procedure, a synthetic oligonucleotide  (36-met) was used 
(5'CTC.GAG.CGT.CTC. ATC. AC  G.GAC. ACA  .GTT.GCA .GC~. ACA.  3').  A 
clone that contained the desired deletion was selected and the complete se- 
quence of a Sst I-Xho II fragment that contained the mutation was deter- 
mined by dideoxy-sequencing using the Sequenase protocol (Vabor  and 
Richardson, 1987). The Sst I-Xho II fragment was inserted into the plasmid 
pSP8800vWF (Verweij et ai., 1986) and, subsequently, the mutant eDNA 
(lacking the domains C1  and C2) was inserted into the plasmid pSVLE 
yielding plasmid pSVLvWFdelC1C2. Plasmid pSVLvWFter2663, was con- 
structed essentially according to the same protocol. As a template for mnta- 
genesis, the M13mp9 phage with the 1,841-bp Bgl II-Eco [] insert described 
above, was used. The introduction of two point mutations, substituting the 
C for T at nucleotide 8216 and the T for A at nucleotide 8218, replaced the 
amino acid residue arginine at position 2663  by a translation termination 
codon. For that purpose an oligonueleotide primer (21-mer)  (5'CGT.CTC. 
ATC.T*CA*.CTT.CAG.TGT3') was used that contained two substitutions (in- 
dicated with *) with regard to the wild-type sequence. The complete se- 
quence ofa Sph I-Eco [] fragment containing the mutation was determined 
and, subsequently, the fragment was inserted into pSP8800vWE  Finally, 
the vWF eDNA containing the mutation was inserted into plasmid pSVLE, 
yielding pSVLvWFter2663. The plasmid pSVLdelD1-C2 was constructed 
as follows. The M13mp9 clone that contained the 1,841-bp Bgl II-Eco [] 
insert described above was digested with Sal I. An Xho I fragment, ranging 
from the Xho I site in the poly-linker of pSVLvWF till the Xho I site at 
nucleotide position 1320 of the vWF cDNA, was inserted into the Sal I site. 
An M13 clone with the described Xho I fragment in the correct orientation 
was selected and the resulting construct, containing both the 5' end as well 
as the 3' end of the vWF eDNA, was used as a template for mutagenesis. 
An oligonucleotide primer (36-mer)  (5'CTG.GAG.CGT.CTC.ATC.ACG.- 
"IV_~.ACA.AAG.GGT.CCC.TGG.3')  was used to  fuse nueleotide 298  of 
vWF cDNA to nucleotide 8215 ofvWF eDNA. A selected clone, containing 
the desired mutation, was picked and the complete sequence of the vWF 
cDNA insert was determined. Next, an Eco [] fragment containing the en- 
tire mutated vWF eDNA was isolated and cloned into pSVLE, yielding 
pSVLvWFdelD1-D2. In this construct, the signal peptide ofvWF including 
the alanine-residue immediately beyond the signal peptide cleavage site is 
linked to the arginine at position 2663. DNA preparations, used for transfec: 
tion of monkey kidney cells (COS-l), were purified by cesium chloride/ 
ethidium-bromide equilibrium centrifugation. 
1Issue Culture and Transfection 
Monkey kidney COS-1 ceils were maintained in Iscove's modified minimal 
medium, supplemented with 100 U/ml penicillin, 100/~g/ml  streptomycin, 
and 10% (vol/vol) FCS. 24 h after seeding, the semiconlluent cells were 
transfected with 40/~g of  plasmid DNA in 4 ml of  Iscove's modified minimal 
medium, supplemented with 200 #g/ml DEAE dextran. This incubation 
was followed by a chloroquine shock (Luthman and Magnusson, 1983). Af- 
ter the transfection, cells were maintained in Iscove's minimal medium. As 
a control, cells transfected with pSV'2/t-PA DNA were used (Van Zonneveld 
et al.,  1986). 
Metabolic Labeling of Transfected Cells 
Transfected cells were maintained in serum-free medium for 70 h  after 
transfection. At this time, the cells were starved for 1 h in RPMI medium, 
lacking either methionine or cysteine. The cell were labeled for 4 h in the 
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specific radioactivity >800 Ci/mmol) or [35S]cysteine (50 t~Ci/ml, specific 
radioactivity >480 Ci/mmol), followed by a chase period  of 16 h with nonla- 
beled methionine  (30 #g/ml).  After radiolabeliug,  the medium was col- 
lected and centrifuged for 5 rain at 1,500 rpm. The calls were washed twice 
with 10 mbl sodium phosphate (pH Z4), 0.14 M NaCI (PBS) and lysed in 
immunoprecipitation buffer 0PB), consisting of 10 mM Tris-HC1 (pH 7.8), 
150 mM NaCI, 5 mM EDTA, 1% (vol/vol) NP-40, 10 mM benzamidine, 
5 mM N-ethy!maleimide and  1 mM PMSE Conditioned media and cell 
extracts obtained  from metabolically labeled ceils were stored at  -80"C 
or used immediately for immunoprecipitation.  Pulse-chase experiments, 
spanning a  shorter period,  were performed  essentially according  to the 
above protocol. 
Immunoprecipitation  ~ 
Preclearing of media and cell extracts was performed by two successive in- 
cubations at room temperature with gelatin-Sepharose and, subsequently, 
with preformed complexes of rabbit preimmune serum coupled to protein 
A-Sepharose. Immunoprecipitation of  radiolabeled vWF was carried out ei- 
ther by preformed complexes of an IgG preparation,  derived from rabbit 
anti-vWF serum (Dakopatts) coupled to protein A-Sepharose or by using 
this anti-vWF serum coupled to cyanogen bromide-activated  Sepharose. 
Immunoprecipitates  were  extensively washed with  immunoprecipitation 
buffer (IPB),  pelleted through a discontinuous  10-20%  (wt/vol) sucrose 
gradient and dissolved in IPB supplemented with 0.5 % desoxycholate and 
10 mM Tris-HC1 (pH 7.8), respectively. After a final wash with  10 mM 
Tris-HC1 (pH ZS), the immunoprecipitates were analyzed by SDS-PAGE 
(Laemmli,  1970). 
vWF Multimer Analysis 
Conditioned media of  transfected cells was harvested three days after trans- 
fection.  After centrifugation  for  5  min at  1,500 rpm,  the conditioned 
medium was adjusted to Ix IPB with 5 times concentrated IPB and then 
concentrated by Centricon-30 (Amicon Corp., Danvers, MA) filtration un- 
til a final concentration of  0.25 ng vWF/#I. Cell extracts of  transfected cells 
were collected  three days post transfection.  An 80-cm  2 flask with trans- 
fected COS-1 cells was washed twice  with PBS. Subsequently, the cells were 
scraped in PBS, collected by centrifugation and lysed in 250/~1 of IPB. Cel- 
lular debris was removed by centrifugation for 30 rain at 15,000 rpm and 
the resulting superrmtant was analyzed.  Discontinuous  SDS-agarose gel 
electrophoresis of 10-#1 samples of  both medium and cell extract on a 0.8 % 
(wt/vol) agarose stacking gel and 2 % (wt/vol) running gel was performed 
as described previously (Ruggeri and Zimmerman,  1981). After electropho- 
resis, the gel was fixed, dried and incubated with afffinity-purified  []~I]- 
labeled rabbit anti-vWF IgG. The multimeric composition of the samples 
were visualized by autoradiugraphy. Partially cross-linked fibrinugen was 
used as a molecular weight marker (Verweij  et al., 1987). Multimeric analy- 
sis of the mutant protein vWFdelD1-C2 was performed by analyzing im- 
munoprecipitates  of metabolically  labeled  COS-I  cells  transfected  with 
pSVLvWF'delDI-C2  under non-reducing conditions on a 15 % (wt/vol) SDS- 
polyacrylamide gel. 
Endoglycosidase H Digestions 
Endoglycosidase H (endo H) digestions were performed  as follows. Cell ex- 
tracts of transfected and metabolically labeled COS-I cells were immuno- 
precipitated as described. Sepharose beads, containing the immunopurified 
vWF, were incubated with ehition buffer (20 mM Tris-HC1 (pH 7.3), 1 mM 
PMSF, 10 mM EDTA, 10 mM benzamidine, 2 mM N-ethylmaleimide, 1% 
(wt/vol) SDS, 20 mM dithiothreitol) for 20 min at 600C. The resulting elu- 
ate was then diluted 10 times in incubation buffer (100 mM sodium acetate 
[pH 5.5], 1 mM PMSF, 10 mM EDTA, 10 mM benzamidine, 2 mM N-ethyl- 
maleimide, 20 t~g/ml  soybean trypsin inhibitor [SBTI], 0.1% [wt/vol] BSA) 
and digested with 50 mU/ml endo H for 16 h at 37"C. Endo H-digested 
samples were analyzed on a 5 % (wt/vol) SDS-polyacrylamide gel, in paral- 
lel with nondigested material  and a mixture of digested and nondigested 
material. 
Immunoelectronmicroscopy 
Transfected COS-1 cells were maintained in serum-containing medium for 
48 h after transfection. At this time the cells were fixed in a mixture of  4% 
paraformaldehyde and 0.5% ghitaraldehyde in 0.1 M phosphate buffer (pH 
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Figure 1. Domain structure of the vWF protein and mutant proteins 
used in this study. The nomenclature of the repeated domains is ac- 
cording to Verweij et al. (1986).  The sites of the vWF protein that 
are cleaved during biosynthesis, behind the signal peptide and be- 
tween the pro-polypeptide and the mature vWF subunit, respec- 
tively, are indicated by vertical arrows.  Mutant proteins lacking 
specific domains or, alternatively, containing point mutations were 
constructed as indicated in Materials and Methods. 
7.2). The cells were scraped from the dishes and embedded in 10% gelatin. 
Ultrathin frozen sections were prepared from the blocks and incubated with 
rabbit anti-vWF antiserum (Dakopatts; dilution 1:100) and gold-conjugated 
goat anti-rabbit IgG (Janssen Pharmaceutica,  Beerse,  Belgium; dilution 
1:40, particle size 10 nm). Both incubations were done for ! h at room tem- 
perature.  The sections were stained with uranyl acetate and embedded in 
methylcellulose. Other gelatin blocks were embedded at low temperature 
with  Lowicryl  K4M  (Bio-Rad  Laboratories,  Veenendaal,  The  Nether- 
lands).  Thin sections were incubated with anti-vWF antiserum  and gold 
conjugate as described above and stained with uranyl acetate and lead ci- 
trate. All the preparations were examined with a Philips CM 10 electron 
microscope. 
Antigen Determination 
The determination of  the amount of  vWF antigen in conditioned media was 
carried out by an ELISA, using rabbit anti-vWF IgG (Dakopatts) as a solid- 
phase and a murine mAb against vWF (CLB RAg35), in conjunction with 
peroxidase-conjugated goat anti-mouse IgG, as a indicator (Reinders et al., 
1985). 
Results 
Expression and Processing of vWF Mutant Proteins 
It has been shown previously that the carboxy-terminal part 
of vWF mediates the formation of intermolecular disulfide 
bonds which results in the formation of vWF dimers (Fretto 
et al.,  1986; Marti et al.,  1987). Here, we have investigated 
the involvement of the different domains present on the vWF 
molecule in this process. Therefore, we constructed a set of 
mutant vWF cDNAs that were expressed in COS-1 cells and 
compared  the  properties  of the resultingmutant  proteins 
with those of the wild-type protein. Full-length vWF qDNA 
served as a starting material for the preparation of the de- 
sired deletion mutants. Fig.  1 shows a schematic representa- 
tion of the mutant vWF cDNAs used in this study. The borders 
of the deleted domains were based on the amino acid homol- 
ogy reported for the domains C1 and C2 (Sadler et al., 1985; 
Verweij et al.,  1986).  Since the region beyond domain C2 
does not display internal homology nor homology with other 
proteins, it was regarded as a single domain and was entire- 
ly "deleted" by the introduction of a translation termination 
codon immediately downstream of domain C2. The resulting 
mutant cDNAs were expressed in COS-1 cells under control 
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pressed in COS-1 ceils. Transfected COS-1 cells were metabolically 
labeled and both conditioned media and cell extracts were immuno- 
precipitated and analyzed under reducing conditions. COS-1 cells 
transfeeted with pSV2/t-PA were treated identically and used as 
controls. (A) Analysis of vWF proteins secreted into the medium: 
lane 1, wild-type vWF; lane 2, vWFdelC1C2; lane 3, vWFter2663; 
lane 4, pSV2/t-PA control (B) Analysis of cell extracts of trans- 
fected cells: lane 1, wild-type vWF; lane 2, vWFdelC1C2; lane 3, 
vWFter2663; lane 4, pSV21t-PA control. The position of the pro- 
vWF and mature vWF subunit of  the wild-type protein are indicated 
by arrows. Molecular weight markers of 200,000 and 92,000 are 
indicated at the left of the figure. 
cells transfected with pSVLvWFter2663 reveals a weak band 
with a molecular weight in between that of  the wild-type pro- 
tein and that of the mutant protein vWFdelC1C2. This obser- 
vation is in accordance with the length of the deletion (151 
amino acids), constituting the extreme carboxy-terminus of 
vWF.  Together, our results show that both mutant protein 
vWFdelC1C2 as well as mutant protein vWFter2663 are not 
secreted by COS-1  cells.  Mutant  protein vWFdelC1C2 is 
present at a level similar to that of wild-type vWF protein 
inside the cell, whereas the mutant protein vWFter2663 is 
present at a lower level inside the cell. 
Multimer Analysis of  Mutant Proteins 
The multimeric structure of the mutant proteins was exam- 
ini~d by performing an electrophoretic analysis on 2%  (wt/ 
vol) SDS-agarose gels (Fig. 3). Staining of the gels was done 
by incubation with ~zSI-labeled  anti-vWF antibodies.  As shown 
before, wild-type vWF secreted by COS-1 cells is present as 
a  multimeric structure (Verweij et al.,  1987,  1988).  Since 
both mutant protein vWFdelC1C2 and mutant protein vWFter- 
2663 are not secreted, multimer analysis of conditioned me- 
dium of ceils transfected with pSVLvWFdelC1C2 and pSVL- 
vWFter2663 obviously did not reveal any signal (data not 
shown). Inspection of  the multimeric pattern obtained for the 
wild-type protein from cell extracts also reveals the presence 
of  the SV-40 "late"  promoter. Transfected cells were metabol- 
ically labeled with [3sS]methionine  and the secreted prod- 
ucts were immunoprecipitated with anti-vWF antibodies and 
analyzed under reducing conditions by 5 %  (wt/vol) SDS- 
PAGE to determine whether the level of expression and the 
pattern of proteolyfic  processing was identical to that of wild- 
type vWF (Fig. 2 A). As has been shown before, transfection 
of COS-1 cells with full-length vWF eDNA yields a mixture 
of  pro-vWF- and mature vWF subunits (Bonthron et al., 1986; 
Verweij et al., 1987). Surprisingly, however, no vWF protein 
could be immunoprecipitated from the conditioned media 
upon expression in COS-1 cells of  the mutant cDNAs pSVL- 
vWFdelC1C2 and pSVLvWFter2663. Subsequently, we ana- 
lyzed cell extracts of metabolically labeled COS-1 cells trans- 
fected with the full-length and mutant cDNAs (Fig. 2 B). As 
shown previously, in transfected COS-1  cells the wild-type 
protein is present in the nonproeessed form (Bonthron et al., 
1986; Verweij et al.,  1988).  Upon analysis of cell extracts 
of  metabolically labeled COS-1 cells transfected with pSVL- 
vWFdelC1C2, a single protein is immunoprecipitated which 
migrates slightly faster than the wild-type protein. The amount 
of the mutant protein vWFdelC1C2 encountered within the 
cell is similar to that of wild-type vWE The apparent molec- 
ular weight of this mutant protein coincides with the deletion 
of the domains C1 and C2 (i.e., 263 amino acids). Further- 
more, like the wild-type protein, the mutant protein vWFdel- 
C1C2  is present intracellularly in the nonprocessed form. 
Since we were not able to detect the mutant protein vWF- 
delC1C2 in the conditioned medium of transfected COS-1 
cells, we conclude that this mutant protein is defective in its 
secretion. 
Analysis of cell extracts of metabolically labeled COS-1 
Figure 3. Multimeric analysis of wild-type vWF and mutant pro- 
teins expressed in COS4 cells media and cell extracts of  cells trans- 
fected with wild-type and mutant cDNAs was analyzed with regard 
to multimeric composition under non-reducing conditions on 2% 
(wt/vol) SDS-agarose gels (Rnggeri and Zimmerman,  1981). (A) 
Multimer composition of conditioned medium of transfected cells; 
lane I, wild-type vWE The position of the dimer consisting of two 
pro-vWF subunits and the dimer consisting of two mature vWF 
subunits is indicated. The large multimers of  wild-type vWF do not 
enter the running gel and are found on top of it. (B) Multimer com- 
position of cell extracts of cells transfected with wild-type and mu- 
tant cDNAs; lane 1, wild-type vWF; lane 2, vWFdelC1C2; lane 3, 
vWFter2663;  lane  4,  pSV2/t-PA control.  Partially  cross-linked 
fibrinogen was used as a molecular weight marker. The position of 
the dimer consisting of two pro-vWF subunits is indicated for the 
wild-type protein. The monomeric form of  mutant protein vWFter- 
2663 is indicated by an arrowhead. Dimeric and multimeric forms 
of wild type-vWF and vWFdelC1C2 are also indicated (,). 
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vWFdelDI-C2. (A) Subunit composition of vWFdelD1-C2. COS-1 
cells transfected with pSVLvWFdelD1-C2 were metabolically la- 
beled, immunoprecipitated and analyzed on a 15 % (wt/vol) SDS- 
polyacrylamide gel under reducing conditions. As a control for the 
specificity of the obtained signal, COS-1 cells transfected with 
pSV2/t-PA were used; lane 1, vWFdelDI-C2; lane 2, pSV2/t-PA 
control. Molecular weight markers are indicated at the right of the 
figure. (B) Multimeric composition of vWFdelD1-C2; COS-1 cells 
transfected with pSVLvWFdelD1-C2 were metabolically labeled, 
immunoprecipitated and analyzed on a  15%  (wt/vol) SDS-poly- 
acrylamide gel under nonreducing conditions; lane 1, vWFdelD1- 
C2; lane 2, pSV2/t-PA control. Molecular weight markers are indi- 
cated at the right of the figure. 
of multimers. Since wild-type vWF is present in the cell ex- 
tract exclusively in the nonprocessed form, only pro-vWF 
multimers are observed.  The main form encountered for 
wild-type vWF is the dimer, whereas only a small portion 
is organized in multimers, in agreement with our previous 
observations (Verweij et al., 1987).  Several bands can be ob- 
served with a higher mobility than the wild-type pro-vWF 
dimer, most likely representing monomeric forms of wild- 
type vWF. The intraceUular,  multimeric pattern obtained for 
the mutant protein vWFdelC1C2 is similar to that of  the wild- 
type protein.  As  anticipated, the prominent vWFdelC1C2 
dimer migrates slightly faster than the wild-type vWF dimer. 
These observations indicate that this mutant protein can di- 
merize and, consequently, is also able to multimerize, since 
the area involved in the latter process has been assigned to 
the distant amino-terminal D domains of the vWF molecule 
(Voorberg  et al.,  1990).  Hence, we conclude that the do- 
mains C1 and C2 do not participate in the formation of vWF 
dimers.  Mnltimer analysis of cell extracts of COSA  cells 
transfected with pSVLvWFter2663, reveals only one band 
which migrates significantly faster than the wild-type vWF 
and vWFdelC1C2  dimer. Clearly, the mutant protein vWF- 
ter2663 is not able to form dimers and is encountered within 
the cell as a monomer. This observation suggests that the re- 
gion beyond domain C2 would be  solely required for the 
generation of dimers. 
Expression and Analysis of  a Mutant vWF Protein 
Containing Only the Region beyond Domain C2 
To demonstrate unambiguously that the region beyond C2 
contains all the requirements for dimerization, a construct 
(pSVLvWFdelD1-C2)  was made on which cDNAs are fused 
which encode the signal peptide and the utmost 151  car- 
boxy-terminal amino acids of vWE Transfected COS-1 cells 
were metabolically labeled with [35S]cysteine and the se- 
creted products were immunoprecipitated and analyzed un- 
der reducing conditions by 15 % (wt/vol) SDS-PAGE (Fig. 4 
A). A single protein is secreted and immunoprecipitated  with 
the expected, apparent molecular weight of 20,000. Analysis 
of the secreted product under nonreducing conditions by 
15 % (wt/vol) SDS-PAGE, yielded a protein with an apparent 
molecular weight of  40,000 (Fig. 4 B), indicating the forma- 
tion of a dimeric product linked by intermolecular disulfide 
bonds. Evidently, the region beyond C2 is capable of dimer- 
ization independent of the presence of other domains of the 
vWF molecule. This finding enables us to conclude that only 
the region beyond domain C2 of vWF is required for dimer- 
ization of vWE 
A Defect in Assembly Results in Aberrant Transport 
of vWF Mutants through the Cell 
In previous paragraphs, we have shown that the mutant pro- 
tein vWFter2663 is unable to dimerize and present at a low 
level inside the cell. We investigated the fate of this protein 
inside the cell more closely, to obtain insight into routing of 
the protein as compared to wild-type vWF and vWFdelC1C2. 
Therefore, COS-1 cells transfected with pSVLvWF, pSVL- 
vWFdelC1C2 and pSVLvWFter2663, were metabolically la- 
beled for  1 h  and followed by chase periods of different 
lengths.  Both cell extracts and media,  obtained after the 
different chase periods were irnmunoprecipitated and ana- 
lyzed under reducing conditions by 5 % (wt/vol) SDS-PAGE 
(Fig.  5).  Autoradiography revealed a  gradual decrease of 
wild-type vWF in the cell, accompanied by a concomitant 
increase of secreted vWF, initiating after a chase of  4 h. After 
this period, a sharp decrease of the amount of wild-type pro- 
tein inside the cell is observed. The fate of the mutant protein 
vWFdelC1C2 inside the cell exactly mimics that of the wild- 
type protein;  again,  the intracellular amount of this vWF 
protein sharply decreases after a 4-h chase. However, in con- 
trast to the wild-type protein, for the mutant protein vWF- 
delC1C2  no concomitant increase of secreted vWF is ob- 
served. Even after a chase of 24 h, no secreted material can 
be detected for the mutant protein vWFdelC1C2,  in accor- 
dance with the data presented in Fig. 2.  Clearly, mutant 
vWFdelC1C2 is defective in secretion and, consequently, the 
synthesized  protein must be degraded inside the cell. Inspec- 
tion of the pattern obtained for mutant protein vWFter2663, 
lacking the utmost 151 amino acids of vWF, reveals that until 
4 h after synthesis this protein behaves identically to wild- 
type vWF. However,  at chase periods longer than 4 h, the 
amount of vWFter2663 found in the cell deviates from the 
amount of wild-type protein. After 8 h, a significant reduc- 
tion in the intraceUular amount of the mutant protein vWF- 
ter2663 is observed, compared with the wild-type protein, 
whereas 24 h after synthesis hardly any protein can be de- 
tected inside the cell (see Fig. 2). Combined with the obser- 
vation that the mutant protein vWFter2663 is not secreted, 
Voorberg  et al. Dimer Assembly of von  Willebrand  Factor  199 Figure 5. Routing of wild-type vWF, vWFdelC1C2, vWFter2663, and vWFdelpro through the cell. Transfeeted COS-1 cells were metaboli- 
cally labeled with [3SS]methionine  for 1 h and chased for 0, 2, 4, 8, and 24 h, respectively. Cell extracts and conditioned media harvested 
after the different chase periods,  immunoprecipitated and analyzed on a 5%  (wt/vol) SDS-polyacrylamide gel.  As a control for the 
specificity of the observed signals COS-1 cells transfected with pSV2/t-PA were used. (A) Analysis of cell extract of transfeeted cells after 
different  periods of chase. In the first panel, the amount of  vWF protein present immediately after 1 h of labeling is given; lanes 1, wild-type 
vWF; lanes 2, vWFdelpro; lanes 3, vWFdelC1C2; lanes 4, vWFter2663; lanes 5, pSV2/t-PA, control. The other four panels indicate periods 
of chase of 2, 4, 8, and 24 h, respectively. A molecular weight marker of 200,000 is indicated. (B) Analysis of conditioned medium of 
transfected cells after different periods of chase. In the first panel, the amount of vWF protein, present in the conditioned medium after 
1 h of labeling is given; lanes 1, wild-type vWF; lanes 2, vWFdelpro; lanes 3, vWFdelC1C2; lanes 4, vWFter2663; lanes 5, pSV2/t-PA, 
control. The other four panels indicate periods of  chase of  2, 4, 8, and 24 h, respectively. A molecular weight marker of  200,000 is indicated. 
we conclude that the mutant protein vWFter2663 is slowly 
degraded inside the cell, starting ,,~4-8 h after synthesis. To- 
gether, the above data provide evidence for the intracellular 
degradation of both mutant proteins vWFter2663 and vWF- 
delC1C2.  However, the rate of degradation is different for 
both proteins. The mutant protein vWFdelC1C2 is degraded 
at a rate that approximately equals the rate of secretion of 
the wild-type protein. In contrast, mutant protein vWFter- 
2663, being unable to dimerize, is degraded at a much faster 
rate. This observation may indicate that the ability to assem- 
ble into dimers and, possibly to assemble into multimers, 
dictates the route followed within the cell. To test this option, 
we investigated the fate of a  previously described mutant 
protein, vWFdelpro, which effectively forms dimers, but is 
unable to multimerize (Verweij  et al.,  1987).  Therefore, a 
pulse chase experiment was done with this mutant protein, 
performed identically to the one described above. Surpris- 
ingly, the mutant vWFdelpro displays a distinct higher secre- 
tion rate than the wild-type protein (Fig. 5). As soon as 2 h 
after synthesis, a decrease of vWFdelpro in the cell extract 
is observed, accompanied by the concomitant appearance of 
the mutant protein in the medium. This observation indicates 
that the inability to form multimers leads to enhanced secre- 
tion. Consequently, a defect in protein assembly is not neces- 
sarily associated with degradation of a protein, as evidenced 
by mutant protein vWFter2663, which is unable to dimerize. 
Rather, the nature of the defect in protein assembly deter- 
mines the fate of the protein. 
Effect of  lnhibitors of  Lysosomal Function on 
the Degradation  of  Mutant Proteins vWFter2663 
and vWFdelCIC2 
In the previous paragraph, we have shown that both mutant 
protein vWFdelCIC2 and vWFter2663 are degraded inside 
the cell. Pulse-chase analysis revealed that mutant protein 
vWFdelC1C2 is degraded much slower than mutant protein 
vWFter2663. To define the intracellular site of degradation 
an identical pulse-chase experiment was carried out as de- 
scribed in Fig.  5, however, in this case in the presence of 
different inhibitors of the lysosomal degradation pathway. 
Clearly,  incubation of the cells with  weak bases  such as 
NI-LC1 and  chloroquine,  which  inactivate lysosomal pro- 
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inhibitors  on  the  routing  of 
wild-type vWF, vWFdelC1C2 
and vWFter2663. Transfected 
COS-1 cells  were  metaboli- 
cally labeled with 13SS]methi  - 
onine for 1 h and chased for 0, 
2, 4, 8, and 24 h, as indicated. 
During starvation, labeling and 
chase either  100/zM chloro- 
quine, 50 mM NI-hCl, or no 
additions  were present.  Cell 
extracts were harvested,  and 
the radiolabeled vWF was im- 
munoprecipitated and analyzed 
on a 5%  (wt/vol) SDS-poly- 
acrylamide gel under reducing 
conditions.  (A)Blanco;  (B) 
incubation with 100 ~M chlo- 
roquine; (C) incubation with 
50 mM NI-hC1. Only the rele- 
vant portions of the gels are 
shown. 
teases, did not effect the routing of either wild-type vWF, 
vWFdelC1C2 and vWFter2663 (Fig. 6). These observations 
indicate that proteolytic degradation of the mutant proteins 
does not involve the lysosomes. In addition,  incubation of 
transfected cells with yet another lysosomal inhibitor (leu- 
peptin), again did not result in inhibition of proteolytic deg- 
radation of  the mutant proteins vWFdelC1C2 and vWFter2663 
(data not shown). Recently, the existence has been reported 
of a nonlysosomal pre-Golgi degradation route (Lippincott- 
Schwartz et al.,  1988). The insensitivity of proteolytic deg- 
radation of mutant proteins vWFdelC1C2 and vWFter2663 
to inhibitors of the lysosornal pathway may indicate that both 
proteins are degraded via this pre-Golgi degradation route. 
Endo H Digestions of Wild-1)~e and Mutant Proteins 
To determine the intraceUular localization of the different 
vWF proteins, we tested the sensitivity of the wild-type and 
mutant proteins towards endo H. Sensitivity of the proteins 
for endo H means that the proteins have not reached the me- 
dial-Golgi, where maturation of asparagine-linked carbohy- 
drate site chains occurs, resulting in endo H resistance (Kom- 
feld and Kornfeld, 1985). Therefore, transfected COS-1 cells 
were pulse labeled for 4 h with [3~Slcysteine and chased for 
16 h. Endo H sensitivity of immunoprecipitated material de- 
rived of cell extracts was tested immediately after the pulse- 
labeling and at the end of the chase-period (Fig.  7).  The 
wild-type protein is sensitive to endo H digestion after the 
4  hour pulse (not shown) and even after a  16-h chase the 
wild-type protein present in the cell is entirely sensitive to 
endo H, indicating that the bulk of the vWF in the cell is re- 
tained in a compartment before the medial-Golgi. Inspection 
of the endo H sensitivity of secreted vWE revealed complete 
resistance to endo H digestion, as expected for a protein that 
has traversed the Golgi apparatus (data not shown). Mutant 
protein vWFdelC1C2, like the wild-type protein, remained 
sensitive to digestion with endo H after the 16-h chase. To 
Figure 7. Endo H sensitivity of 
wild-type vWF, vWFdelC1C2 
and vWFter2663. Transfected 
cells  were  metabolically  la- 
beled for 4 h and chased for 
16 h. Cell extracts were har- 
vested at that time, immuno- 
precipitated and part of it yeas 
digested with endo H. In the 
first panel the endo H sensitiv- 
ity of wild-ty~ protein is ad- 
dressed;  lanes  1,  nontreated 
immunoprecipitate;  lanes  2, 
mixture of  endo H-treated and 
non-treated immunoprecipitate; lanes 3, endo H-treated immunoprecipitate. A molecular weight marker of 200,000 is indicated at the 
left of the  figure. The endo H-sensitive forms are  indicated by an arrow. The other two panels  represent the endo H sensitivity of 
vWFdelC1C2 and vWFter2663, respectively. 
Voorberg et al. Dimer Assembly of yon WiUebrand  Factor  201 Figure 8. Immunolocalization of wild-type protein in COS-1 cells transfected with vWFcDNA. (A) Lowicryl K4M thin section showing 
labeling in the cisternae of ribosome-studded ER (arrows), a lysosome (ly) is unlabeled. (B and C) Ultrathin frozen sections, with high 
density of labeling in RER (arrows), in B the cisternae of the RER have been distended, mitochondria (m) and plasma membrane were 
not labeled. Bar, 0.5 ~m. 
analyze the mutant protein vWFter2663,  we adjusted  the 
chase period to 4 h, since the amount of this mutant protein 
in  the  cell  rapidly  decreases  upon  longer chase  periods. 
Again,  only endo H  sensitive forms of the mutant protein 
vWFter2663 are encountered in the cell. In conclusion, the 
major part both of wild-type vWF and of the mutant proteins 
vWFdelC1C2 and vWFter2663, are retained in a compart- 
ment prior to the medial-Golgi. 
Immunoelectron Microscopy of Valid-Type vWF 
and Mutant Proteins in Transfected COS-1 Cells 
In the previous section, we have shown that both wild-type 
vWF and mutant vWF proteins are present in a compartment 
before the medial Golgi. To determine the localization of  the 
wild-type and mutant proteins in the cell in more detail, im- 
munoelectronmicroscopy  was performed on ultrathin frozen 
sections and Lowicryl K4M sections of transfected COS-1 
cells.  Analysis of COS-1  cells,  transfected with wild-type 
vWF cDNA,  showed labeling of the cisternae of the RER 
(Fig. 8). In Lowicryl K4M, thin sections (Fig. 8 A), the reac- 
tion with ribosome-studded ER is clearly visible, although 
the intensity of labeling was weaker than on thin frozen sec- 
tions (Fig.  g, B  and C).  No labeling was observed on the 
lysosomes, mitochondria,  cytoplasm or the plasma  mem- 
brane.  Together with our biochemical data,  this  indicates 
that wild-type vWF is predominantly located in the RER. 
The mutant protein vWFdelC1C2 displayed a pattern identi- 
cal to that of the wild-type protein. Also for this mutant pro- 
tein label was exclusively associated with the RER (data not 
shown).  Analysis  of  the  localization  of  mutant  protein 
vWFter2663,  revealed that like the wild-type protein and 
vWFdelC1C2 this protein resides in the RER (Fig. 9, A and 
B). Again, no labeling of ly~osomes was observed, in agree- 
ment with the inability of lysosomal inhibitors to prevent 
degradation of the mutant proteins vWFdelC1C2 and vWFter- 
2663.  Apparently, exit from the ER is a  rate-limiting step 
The Journal of Cell Biology,  Volume 113, 1991  202 Figure 9. Localization of the mutant protein vWFter2663 on ultrathin frozen sections of COS-1 cells transfected with pSVLvWFter2663 
DNA. (A) Area of  a cell with profiles of  labeled RER (arrows). (B) High magnification of  labeled RER (arrows). (C) Area of  a cell showing 
autophagic vacuoles (Av) containing segments of labeled ER. Inset, higher magnification of marked area showing two autophagosomes. 
The membranes of the tubular (t) and vesicular (v) ER are clearly visible, labeling is in the lumen. These structures are comparable to 
the labeled RER shown A. Bars: (A and C) 0.5 #m; (B and C, inset) 0.1 #m. 
both for the ultimate assembly of wild-type vWF multimers 
and for the degradative events associated with the mutant 
proteins vWFdelC1C2 and vWFter2663.  During  our mor- 
phological studies,  on cells transfected with vWFter2663 
cDNA, autophagosomes were detected, specifically labeled 
with anti-vWF antiserum (Fig. 9  C). These structures con- 
sist of bodies that contained segregated portions of cytoplasm 
surrounded by a membrane. Vesicular and tubular elements 
(Fig. 9 C, inset), reminiscent of segments of ER, labeled on 
their "lumenai" aspect, could be recognized in these auto- 
phagosomes. 
In all experiments described, ,-5 % of  the cells were trans- 
fected with plasmid DNA. The untransfected cells in the sec- 
tions were observed as negative control for the specificity of 
the reaction. None of these ceils showed labeling with anti- 
vWF antiserum. 
Discussion 
Dimerization of vWF involves the formation of intermolecu- 
lar  disulfide-bridges at  the  carboxy-terminus of the  vWF 
molecule (Fretto et ai.,  1986). A detailed inspection of the 
disulfide bridge organization of  vWF derived with plasma re- 
veaied that intermolecular disulfide bridges are located be- 
tween amino acid residues 2689 and amino acid 2813 ofvWF 
(Marti et al., 1987). The aforementioned study, however, did 
not exclude the presence of intermolecular disulfide bridges 
in the domains C1 and C2, since this region of the vWF was 
not covered in their studies.  Recently, these domains have 
been implicated in oligomerization, based on the homology 
of this part of the vWF with the oligomeric proteins throm- 
bospondin and procollagen (Hunt and Barker, 1987). In this 
paper, we clearly show that a mutant protein, lacking the do- 
mains C1 and C2, is able to form dirners and conclude that 
this part of the molecule is not involved in dimerization of 
vWF. Both our results with the mutant protein vWFter2663, 
lacking the extreme carboxy-terminus of vWF,  and vWF- 
delD1-C2 show that solely the utmost 151 carboxy-terminai 
amino acid residues of vWF are responsible for dimeriza- 
tion. Previously, we have shown that multimer assembly, in- 
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nus of vWF, requires only the amino-terminal D domains of 
vWF (Voorberg et al.,  1990). Together with our current ob- 
servation on the involvement of the region beyond domain C2 
in dimerization,  the areas of vWF involved in the multimer 
assembly of vWF have now definitely been assigned. 
The time course of vWF biosynthesis, dimerization,  car- 
bohydrate maturation and multimer assembly reveals remark- 
able features. The majority of vWF present in the cell is en- 
countered in the dimeric form (Fig.  3), indicating  that the 
rate-limiting step in assembly is before or at the level of mul- 
timerization. In accord with this assumption are the data on 
the routing of vWFdelpro, a  mutant unable to multimerize, 
and secreted significantly faster than wild-type vWF (Fig. 5). 
In  addition,  both biochemical  and  morphological  data  of 
both wild-type vWF and the vWF mutant proteins demon- 
strate an accumulation of material in the ER. Since relatively 
few wild-type multimers are detected in cell extracts, we as- 
sume that upon a time-requiring initial multimerization pro- 
cess, these proteins are then rapidly, secreted. It should be 
noted that similar observations have been made on synthesis 
and assembly ofvWF in cultured vascular endothelial cells 
(Wagner  and  Marder,  1984).  Also in  these cells,  part of 
the vWF is encountered as endo H-sensitive material  that 
is mainly present in the dimeric form.  Hence, transfected 
COS-1 ceils serve as a suitable model system to study the 
constitutive secretory pathway for vWF-1 of endothelial cells, 
without interference of a regulated secretory pathway. 
Our observations on the routing and the fate of the mutant 
protein vWFdelC1C2 are puzzling. Its properties to assemble 
into dimers and, subsequently, into multimers are similar to 
those exhibited by the wild-type protein. Despite its correct 
assembly, the mutant protein vWFdelC1C2 is not secreted, 
but instead degraded inside the cell. As yet we cannot present 
an explanation for the degradation of this mutant protein. It 
could be  argued  that  the  mutant  protein  vWFdelC1C2  is 
partly  malfolded,  and thus  retained.  Although  we cannot 
fully exclude this possibility, the fact that this mutant protein 
is able to assemble into dimers and multimers,  in our view 
argues against malfolding.  Our morphological data clearly 
show that,  like the wild-type protein,  vWFdelCIC2 is pre- 
dominantly present in the ER. After exit from the ER, the 
wild-type protein is transported rapidly through the Golgi- 
apparatus to the outside of the cell. The proteolytic degrada- 
tion of mutant protein vWFdelC1C2 is insensitive to inhibi- 
tor's of the lysosomal pathwhy (Fig.  5), in accord with our 
morphological data which dirt not reveal specific staining of 
lysosomes with polyclonal anti-vWF antibodies. Recently, a 
degradation  route from the ER has been described for the 
a-chain of the T cell receptor, the H2 subunlt of the asialo- 
glycoprotein receptor and a mutant of the serpin cxl-antitryp- 
sin (Lippincott-Schwartz et al.,  1988; Amara et al.,  1990; 
Le et al.,  1990). In view of the properties of vWFdelC1C2, 
it is conceivable that this degradative route is pursued by this 
mutant protein. Numerous studies with oligomeric proteins, 
e.g., the asialoglycoprotein receptor, inununoglobulins,  the 
T cell receptor and the influenza virus hemagglutinin,  have 
indicated a close correlation between the assembly of a pro- 
tein mad its routing through the cell (Bole et al., 1986; Cope- 
land et al.,  1988; LippincoWSchwartz et al.,  1988; Amara 
et al.,  1989; Doms et al.,  1987). These studies demonstrate 
that a defect in the oligomer assembly of a protein results 
in retention or proteolytic degradation of the nonassembled 
product at the site of oligomer-assembly, i.e., the ER (Lod- 
ish, 1988). The behavior of the mutant protein vWFter2663 
strictly follows the pattern outlined above. The inability of 
this protein to undergo dimerization in the ER, its sensitivity 
to endo H and its relatively fast rate of degradation are com- 
patible with the view that this protein is degraded from the 
ER. This assumption is further substantiated by insensitivity 
of the proteolytic degradation of vWFter2663 to inhibitors 
of lysosomal degradation.  The  linkage  between assembly 
and routing is further illustrated by the properties of the mu- 
tant protein vWFdelD1-C2, containing  only the region be- 
yond domain C2.  This mutant protein is able to assemble 
into dimers and, subsequently, readily transported from the 
ER, through the secretory pathway as evidenced by its ap- 
pearance in the conditioned medium. 
In this paper, we describe two mutant vWF proteins which 
conceivably are degraded from the ER. It has been suggested 
that autophagosomes may be the site of degradation from the 
ER (Lippincott-Schwartz et al.,  1988). Here, we report that 
in COS-1  cells transfected with pSVLvWFter2663, but not 
in COS-1 cells transfected with wild-type vWF, autophago- 
somes were detected which contain vWF (Fig. 9 C). These 
observations are suggestive for a role of the autophagosome 
in  degradation  of this  mutant  protein  from the  ER.  The 
properties of mutant protein vWFdelC1C2 indicate that this 
mutant protein is also degraded from the ER. However, in 
COS-1  cells transfected  with  vWFdelC1C2 no autophago- 
somes could be detected. Since the degradation of vWFdel- 
C1C2  proceeds much slower than  that of vWFter2663, the 
number of autophagosomes present in the transfected COS-1 
cell may significantly differ for these two mutant proteins. 
So far, morphological examinations have been limited by the 
frequency of vWF-transfected cells among the population of 
untransfected  COS-1  cells.  Currently,  we are  establishing 
stable cell lines expressing either wild-type vWF, vWFdel- 
C1C2 or vWFter2663, to enable a more thorough analysis of 
the relation between protein degradation from the ER and the 
occurrence of autophagosomes. 
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